The 1 cases of robotic-assisted laparoscopic radical prostatectomy according to D'Amico risk criteria

European Journal of Surgical Oncology

Volumn 39, Issue 1, 2013, Pages 107-113

  Ou, Y C ^a,b,c   Yang, C K ^a   Wang, J ^d   Hung, S W ^d   Cheng, C L ^a   Tewari, A K ^e   Patel, V R ^f  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHI NAN UNIVERSITY   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^f Global Robotic Institute at Florida Hospital   (United States)

Author keywords

Complication; Prostate cancer; Radical prostatectomy; Robotics; Trifecta

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER CONTROL; CANCER RECURRENCE; CONTROLLED STUDY; D AMICO RISK CRITERIA; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LAPAROSCOPIC SURGERY; LENGTH OF STAY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OUTCOME ASSESSMENT; PENIS ERECTION; PEROPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; ROBOTIC ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY; SURGICAL APPROACH; SURGICAL TECHNIQUE; URETHRAL CATHETERIZATION; URINE INCONTINENCE; AGED; FACTUAL DATABASE; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PATIENT SELECTION; PROSTATE TUMOR; RISK FACTOR; ROBOTICS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PENILE ERECTION; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; ROBOTICS; TREATMENT OUTCOME; URINARY INCONTINENCE;

EID: 84870891978     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.10.003     Document Type: Article

References (29)

1. M.R. Cooperberg, D.P. Lubeck, S.S. Mehta, P.R. Carroll CaPSURE Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE) J Urol 170 6 Pt 2 2003 S21 S25.
2. S.L. Galper, M.H. Chen, W.J. Catalona, K.A. Roehl, J.P. Richie, and A.V. D'Amico Evidence to support a continued stage migration and decrease in prostate cancer specific mortality J Urol 175 3 Pt 1 2006 907 912.
3. J. Noldus, M. Graefen, A. Haese, R.P. Henke, P. Hammerer, and H. Huland Stage migration in clinically localized prostate cancer Eur Urol 38 1 2000 74 78.
4. M.R. Cooperberg, S. Hinotsu, and M. Namiki Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy J Clin Oncol 27 26 2009 4306 4313.
5. H. Akaza, M.A. Moore, and S.J. Chang The 5th conference on Asian trends in prostate cancer hormone therapy Asian Pac J Cancer Prev 8 1 2007 3 12.
6. Y.S. Pu, H.S. Chiang, C.C. Lin, C.Y. Huang, K.H. Huang, and J. Chen Changing trends of prostate cancer in Asia Aging Male 7 2 2004 120 132.
7. Y.C. Ou, C.R. Yang, and J. Wang The learning curve for reducing complications of robotic-assisted radical prostatectomy by a single surgeon BJU Int 108 3 2011 420 425.
8. L. Salomon, F. Saint, A.G. Anastasiadis, P. Sebe, D. Chopin, and C.C. Abbou Combined reporting of cancer control and functional results of radical prostatectomy Eur Urol 44 6 2003 656 660.
9. F.J. Bianco Jr., P.T. Scardino, and J.A. Eastham Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta") Urology 66 5 Suppl. 2005 83 94.
10. J.W. Saranchuk, M.W. Kattan, E. Elkin, A.K. Touijer, P.T. Scardino, and J.A. Eastham Achieving optimal outcomes after radical prostatectomy J Clin Oncol 23 18 2005 4146 4151.
11. J.A. Eastham, P.T. Scardino, and M.W. Kattan Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram J Urol 179 6 2008 2207 2211.
12. G. Ploussard, A. de la Taille, and E. Xylinas Prospective evaluation of combined oncological and functional outcomes after laparoscopic radical prostatectomy: trifecta rate of achieving continence, potency and cancer control at 2 years BJU Int 107 2 2011 274 279.
13. V.R. Patel, R.F. Coelho, and S. Chauhan Continence, potency and oncological outcomes after robotic-assisted radical prostatectomy: early trifecta results of a high-volume surgeon BJU Int 106 5 2010 696 702.
14. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 11 1998 969 974.
15. Y.C. Ou, S.W. Hung, J. Wang, C.K. Yang, C.L. Cheng, and A.K. Tewari Retro-apical transection of the urethra during robot-assisted laparoscopic radical prostatectomy in an Asian population BJU Int 110 2b 2012 E57 E63.
16. A.K. Tewari, A. Takenaka, and E. Mtui The proximal neurovascular plate and the tri-zonal neural architecture around the prostate gland: importance in the athermal robotic technique of nerve-sparing prostatectomy BJU Int 98 2 2006 314 323.
17. A.K. Tewari, S. Rao, and J.I. Martinez-Salamanca Cancer control and the preservation of neurovascular tissue: how to meet competing goals during robotic radical prostatectomy BJU Int 101 8 2008 1013 1018.
18. A.K. Tewari, K. Bigelow, and S. Rao Anatomic restoration technique of continence mechanism and preservation of puboprostatic collar: a novel modification to achieve early urinary continence in men undergoing robotic prostatectomy Urology 69 4 2007 726 731.
19. P.F. Coelho, S. Chauhan, and M.A. Orvieto Influence of modified posterior reconstruction of the rhabdosphincter on early recovery of continence and anastomotic leakage rates after robot-assisted radical prostatectomy Euro Urol 59 1 2011 72 80.
20. P.M. Pierorazio, B.A. Spencer, T.R. McCann, J.M. McKiernan, and M.C. Benson Preoperative risk stratification predicts likelihood of concurrent PSA-free survival, continence, and potency (the trifecta analysis) after radical retropubic prostatectomy Urology 70 4 2007 717 722.
21. E. Antebi, A. Eldefrawy, D. Katkoori, C.T. Soloway, M. Manoharan, and M.S. Soloway Oncological and functional outcomes following open radical prostatectomy: how patients may achieve the "Trifecta"? Int Braz J Urol 37 3 2011 320 327.
22. S.A. Shikanov, K.C. Zorn, G.P. Zagaja, and A.L. Shalhav Trifecta outcomes after robotic-assisted laparoscopic prostatectomy Urology 74 3 2009 619 623.
23. G. Novara, V. Ficarra, C. D'Elia, S. Secco, S. Cavalleri, and W. Artibani Trifecta outcomes after robot-assisted laparoscopic radical prostatectomy BJU Int 107 1 2011 100 104.
24. V.R. Patel, A. Sivaraman, and R.F. Coelho Pentafecta: a new concept for reporting outcomes of robot-assisted laparoscopic radical prostatectomy Eur Urol 59 5 2011 702 707.
25. E. Xylinas, X. Durad, and G. Ploussard Evaluation of combined oncologic and functional outcomes after robotic-assisted laparo-scopic extraperitoneal radical prostatectomy: trifecta rate of achieving continence, potency and cancer control Urol Oncol 2011 Jun 28 [Epub ahead of print].
26. E. Xylinas, G. Ploussard, and X. Durand Evaluation of combined oncological and functional outcomes after radical prostatectomy: trifecta rate of achieving continence, potency and cancer control - a literature review Urology 76 5 2010 1194 1198.
27. V. Ficarra, P. Sooriakumaran, and G. Novara Systematic review of methods for reporting combined outcomes after radical prostatectomy and proposal of a novel system: the survival, continence, and potency (SCP) classification Eur Urol 61 3 2011 541 548.
28. J. Schmitges, Q.D. Trinh, J. Walz, and M. Graefen Surgery for high-risk localized prostate cancer Ther Adv Urol 3 4 2011 173 182.
29. C.L. Amling, M.L. Blute, and E.J. Bergstralh Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years J Urol 164 1 2000 101 105